Plate of medicines


Life sciences and health care M&A update: Q1 2019

The life science and health care industry is starting to put more emphasis on using analytics to help overcome common challenges and find new industry wins. Many companies in the health care sphere are putting analytics at the top of their priority lists with efforts such as adding C-suite roles focused on analytics, establishing analytics strategies, and designing processes to help with data reviews. Life Sciences & Health Care mergers & acquisitions (M&A) update provides Deloitte Corporate Finance LLC insights and market data analysis that shed light on M&A trends in the life sciences and health care industry.

How 3D printing can revolutionize health care

Health systems strategic focus on analytics1

The health care industry is counting on analytics to help it overcome many of its challenges and unlock value from evolving and new data sources.

Analytics is a necessary capability to help shift to value-based payment models and can help health systems deliver higher quality of care while improving operations and lowering costs. It is also important for strategies and initiatives that depend on data mining—such as understanding social determinants of health and the importance of customer experience and preferences. Heading into the future, data analytics is expected to be one of the backbones for health systems seeking to use emerging technologies such as artificial intelligence (AI) and robotic process automation (RPA) to transform their care delivery or workforce.

Health systems are increasingly making analytics a priority, as their planning, governance, and investments show. They recognize its importance for their strategies today and even more so for the future. The Deloitte Center for Health and Solutions measured changes in analytics maturity across four areas, including having: (i) a defined strategy and vision; (ii) a dedicated analytics department; (iii) chief analytics leadership; and (iv) a formal data governance process.1

Investment into analytics2

The Deloitte Center for Health Solutions (DCHS) conducted research to see if health systems have increased their investments and use of analytics for clinical, operational, and financial functions. In late 2018, DCHS surveyed 56 chief information officers (CIOs), chief technology officers (CTOs), and chief analytics executives at health systems in order to understand today’s landscape and compare it with findings from the 2015 survey on the same topic.

When it comes to analytics, health systems in 2018 are more likely to have:

  • Defined strategies and visions (70 percent in 2018 vs. 40 percent in 2015);
  • Dedicated departments (88 percent in 2018 vs. 76 percent in 2015); and
  • Centralized governance models (68 percent in 2018 vs. 58 percent in 2015)

C-suite role3

Organizations are now more likely to have a C-suite role dedicated to analytics (30 percent had a chief analytics officer in 2018 vs. 12 percent in 2015).

Organizational strategy4

84 percent of executives say that analytics will be extremely important for their organization’s strategies in three years, compared to 36 percent who say analytics are extremely important today.

This newsletter is a periodic compilation of certain capital markets information. Information contained in this newsletter should not be construed as a recommendation to sell or a recommendation to buy any security. Any reference to or omission of any reference to any company in this newsletter shall not be construed as a recommendation to sell, buy, or take any other action with respect to any security of any such company. We are not soliciting any action with respect to any security or company based on this newsletter. This newsletter is published solely for the general information of clients and friends of Deloitte Corporate Finance LLC. It does not take into account the particular investment objectives, financial situation, or needs of individual recipients. Certain transactions, including those involving early-stage companies, give rise to substantial risk and are not suitable for all investors. This newsletter is based on information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon as such. Prediction of future events is inherently subject to both known risks, uncertainties, and other factors that may cause actual results to vary materially. We are under no obligation to update the information contained in this newsletter. We and our affiliates and related entities, partners, principals, directors, and employees, including persons involved in the preparation or issuance of this newsletter, may from time to time have “long” and “short” positions in, and buy or sell, the securities, or derivatives (including options) thereof, of companies mentioned herein. The companies mentioned in this newsletter may be: (i) investment banking clients of Deloitte Corporate Finance LLC; or (ii) clients of Deloitte Financial Advisory Services LLP and its related entities. The decision to include any company for mention or discussion in this newsletter is wholly unrelated to any audit or other services that Deloitte Corporate Finance LLC may provide or to any audit services or any services that any of its affiliates or related entities may provide to such company. No part of this newsletter may be copied or duplicated in any form by any means, or redistributed without the prior written consent of Deloitte Corporate Finance LLC.


1 Alison Hagan, Casey Graves, Dan Kinsella, and Wendy Gerhardt, Shifting into high gear: Health systems have a growing strategic focus on analytics today for the future, Deloitte Insights. 2019., accessed April 14, 2019.

Did you find this useful?